Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
Gender Reversal in the Field of Rheumatology
Behind rheumatology’s ongoing transformation from a specialty whose members are overwhelmingly male, to one that is overwhelmingly female
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
ACR/ARHP Annual Meeting Networking
The 2012 ACR/ARHP Annual Meeting is an opportunity to network with rheumatology colleagues from around the world.
American College of Rheumatology Award Provides Researchers Time for Career Development
The ACR Research and Education Foundation (REF) initiated the ACR REF Rheumatology Investigator Award, which supports junior investigators as they are developing a project that will compete for NIH funding.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
Outstanding ARHP Program Planned for the ACR/ARHP Annual Meeting
The primary tracks at the meeting will focus on clinical practice, clinical science, basic science, and business/administration; four subtracks will include sessions relevant for educators, those interested in pediatrics, practice managers, and rheumatology trainees.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
- « Previous Page
- 1
- …
- 94
- 95
- 96
- 97
- 98
- …
- 103
- Next Page »